Cormorant Asset Management, LP - 15 May 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role: Former 10% Owner
Signature: CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member
Issuer symbol: OKUR
Transactions as of: 15 May 2025
Net transactions value: -$3,363,023
Form type: 4
Filing time: 19 May 2025, 17:33:06 UTC
Previous filing: 14 May 2025
Next filing: 08 Dec 2025
SEC: View on sec.gov

Reporting Owners (6)

Name	Relationship	Address	Signature	Signature date	CIK
Cormorant Asset Management, LP	Former 10% Owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON	CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member	19 May 2025	0001583977
Cormorant Global Healthcare Master Fund, LP	Former 10% Owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON	CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP By: Cormorant Global Healthcare GP, LLC, its General Partner By: /s/ Bihua Chen, Managing Member	19 May 2025	0001618442
Cormorant Private Healthcare Fund III LP	Former 10% Owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON	CORMORANT PRIVATE HEALTHCARE FUND III, LP By: Cormorant Private Healthcare GP III, LLC, its General Partner By: /s/ Bihua Chen , Managing Member	19 May 2025	0001817320
Cormorant Private Healthcare Fund IV LP	Former 10% Owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON	CORMORANT PRIVATE HEALTHCARE FUND IV, LP By: Cormorant Private Healthcare GP IV, LLC, its General Partner By: /s/ Bihua Chen, Managing Member	19 May 2025	0001871297
Cormorant Private Healthcare Fund V LP	Former 10% Owner	200 CLARENDON STREET, 52ND FLOOR, BOSTON	CORMORANT PRIVATE HEALTHCARE FUND V, LP By: Cormorant Private Healthcare GP V, LLC, its General Partner By: /s/ Bihua Chen, Managing Member	19 May 2025	0001969296
Chen Bihua	Former 10% Owner	C/O CORMORANT ASSET MANAGEMENT, LP, 200 CLARENDON STREET, 52ND FLOOR, BOSTON	/s/ Bihua Chen	19 May 2025	0001599214

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OKUR	Class A Common Stock	Sale	$3,363,023	-1,813,439	-100%	$1.85	0	15 May 2025	See Footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Cormorant Asset Management, LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP ("Fund III"), Cormorant Private Healthcare Fund IV, LP ("Fund IV") and Cormorant Private Healthcare Fund V, LP ("Fund V"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP.
F2	Represents the weighted average sale price of Class A Common Stock (the "shares") sold in a series of open market transactions on the transaction date ranging from $1.85 to $2.03 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

Content

Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP ("Fund III"), Cormorant Private Healthcare Fund IV, LP ("Fund IV") and Cormorant Private Healthcare Fund V, LP ("Fund V"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP.

Represents the weighted average sale price of Class A Common Stock (the "shares") sold in a series of open market transactions on the transaction date ranging from $1.85 to $2.03 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.